BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Liver fibrosis
1
Echoes of ancient wisdom and synergistic strategies invigorate the fight against liver fibrosis
6/30/2026 1:40:20 PM | Browse: 7 | Download: 43
2
Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis
2/12/2026 11:20:21 AM | Browse: 98 | Download: 490
3
Levodopa: A novel therapeutic prospect for liver disease
2/12/2026 11:20:20 AM | Browse: 140 | Download: 338
4
Should the theory of methotrexate-induced liver toxicity be abandoned?
2/12/2026 11:20:20 AM | Browse: 120 | Download: 360
5
Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease
1/27/2026 10:12:30 AM | Browse: 163 | Download: 262
6
Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection
1/16/2026 11:31:19 AM | Browse: 114 | Download: 455
7
He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro
12/26/2025 10:27:30 AM | Browse: 119 | Download: 416
8
Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway
12/19/2025 10:39:43 AM | Browse: 109 | Download: 433
9
Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications
12/10/2025 7:48:07 AM | Browse: 157 | Download: 336
10
Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis
12/10/2025 7:48:07 AM | Browse: 120 | Download: 311
11
Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
11/27/2025 7:53:54 AM | Browse: 93 | Download: 322
12
Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis
11/6/2025 8:56:33 AM | Browse: 142 | Download: 525
13
Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice
10/27/2025 10:57:50 AM | Browse: 316 | Download: 429
14
Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy
10/27/2025 10:57:49 AM | Browse: 265 | Download: 466
15
Revitalizing liver health: Human placental extract shows promise in chronic liver disease management
10/11/2025 9:30:02 AM | Browse: 134 | Download: 328
16
Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
9/25/2025 11:24:03 AM | Browse: 182 | Download: 516
17
Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature
9/19/2025 7:57:22 AM | Browse: 546 | Download: 463
18
Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment
9/5/2025 6:36:19 AM | Browse: 521 | Download: 493
19
Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats
9/1/2025 8:05:37 AM | Browse: 616 | Download: 528
20
Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study
8/5/2025 8:25:49 AM | Browse: 166 | Download: 699
21
Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus
8/5/2025 8:25:47 AM | Browse: 196 | Download: 653
22
Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review
8/4/2025 12:11:34 PM | Browse: 169 | Download: 484
23
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
7/25/2025 12:09:44 PM | Browse: 227 | Download: 529
24
Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease
7/25/2025 12:09:41 PM | Browse: 234 | Download: 694
25
FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation
7/24/2025 7:47:20 AM | Browse: 220 | Download: 720
26
Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis
7/15/2025 8:26:32 AM | Browse: 222 | Download: 851
27
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease
7/4/2025 9:23:53 AM | Browse: 230 | Download: 752
28
Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study
6/26/2025 7:27:57 AM | Browse: 165 | Download: 902
29
Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients
6/23/2025 7:18:41 AM | Browse: 260 | Download: 935
30
Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence
6/6/2025 9:35:52 AM | Browse: 118 | Download: 548
31
Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism
5/28/2025 7:32:59 AM | Browse: 155 | Download: 702
32
Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates
5/27/2025 7:04:49 AM | Browse: 226 | Download: 560
33
Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B
5/27/2025 7:04:48 AM | Browse: 256 | Download: 798
34
Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker
4/25/2025 8:23:06 AM | Browse: 227 | Download: 870
35
Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease?
4/25/2025 8:23:02 AM | Browse: 229 | Download: 505
36
Global trends in artificial intelligence applications in liver disease over seventeen years
3/26/2025 4:06:51 AM | Browse: 248 | Download: 1046
37
Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction
3/5/2025 9:35:47 AM | Browse: 186 | Download: 585
38
Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison
2/20/2025 8:40:29 AM | Browse: 158 | Download: 728
39
Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study
1/20/2025 7:38:55 AM | Browse: 200 | Download: 872
40
Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction
1/6/2025 8:47:56 AM | Browse: 163 | Download: 614
41
Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis
1/6/2025 8:47:54 AM | Browse: 226 | Download: 847
42
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model
12/30/2024 6:47:30 AM | Browse: 154 | Download: 565
43
Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease
12/20/2024 3:53:49 AM | Browse: 267 | Download: 714
44
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease
12/20/2024 3:53:47 AM | Browse: 266 | Download: 686
45
Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes
11/29/2024 8:40:09 AM | Browse: 193 | Download: 848
46
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
11/29/2024 8:40:08 AM | Browse: 225 | Download: 620
47
Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function
10/31/2024 10:42:49 AM | Browse: 222 | Download: 786
48
Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis
10/23/2024 4:32:16 AM | Browse: 207 | Download: 705
49
Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
10/17/2024 2:38:59 PM | Browse: 240 | Download: 885
50
Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease
10/16/2024 6:29:25 AM | Browse: 292 | Download: 681
Write to the Help Desk
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.